| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 9.02e-09 | 18 | 83 | 5 | GO:0015278 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.30e-08 | 151 | 83 | 9 | GO:0015085 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 1.71e-07 | 31 | 83 | 5 | GO:0099604 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 2.38e-07 | 33 | 83 | 5 | GO:0005217 | |
| GeneOntologyMolecularFunction | calcium channel activity | 1.10e-06 | 129 | 83 | 7 | GO:0005262 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CACNA1B SLC13A1 RASA3 CACNA2D2 ATP2A1 ATP2A3 RYR1 RYR2 KCNH5 ITPR2 ITPR3 | 3.46e-06 | 465 | 83 | 11 | GO:0046873 |
| GeneOntologyMolecularFunction | gated channel activity | 1.02e-05 | 334 | 83 | 9 | GO:0022836 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 1.26e-05 | 343 | 83 | 9 | GO:0005261 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CACNA1B PIEZO2 SLC13A1 RASA3 CACNA2D2 ATP2A1 ATP2A3 RYR1 RYR2 KCNH5 ITPR2 ITPR3 | 1.85e-05 | 664 | 83 | 12 | GO:0008324 |
| GeneOntologyMolecularFunction | calmodulin binding | 4.85e-05 | 230 | 83 | 7 | GO:0005516 | |
| GeneOntologyMolecularFunction | inositol 1,4,5-trisphosphate-gated calcium channel activity | 5.11e-05 | 3 | 83 | 2 | GO:0005220 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | CACNA1B SLC13A1 RASA3 CACNA2D2 ATP2A1 ATP2A3 RYR1 RYR2 KCNH5 ITPR2 ITPR3 | 5.56e-05 | 627 | 83 | 11 | GO:0022890 |
| GeneOntologyMolecularFunction | calcium-dependent ATPase activity | 1.02e-04 | 4 | 83 | 2 | GO:0030899 | |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 1.02e-04 | 4 | 83 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | chondroitin 4-sulfotransferase activity | 1.02e-04 | 4 | 83 | 2 | GO:0047756 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CACNA1B PIEZO2 SLC13A1 RASA3 CACNA2D2 ATP2A1 ATP2A3 RYR1 RYR2 KCNH5 ITPR2 ITPR3 | 1.03e-04 | 793 | 83 | 12 | GO:0015075 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 1.21e-04 | 459 | 83 | 9 | GO:0005216 | |
| GeneOntologyMolecularFunction | pyruvate dehydrogenase (acetyl-transferring) kinase activity | 1.69e-04 | 5 | 83 | 2 | GO:0004740 | |
| GeneOntologyMolecularFunction | transporter activity | NPC1 CACNA1B ATP8B3 PIEZO2 SLC13A1 RASA3 CACNA2D2 APOB ATP2A1 ATP2A3 RYR1 RYR2 KCNH5 ITPR2 ITPR3 | 2.47e-04 | 1289 | 83 | 15 | GO:0005215 |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 2.53e-04 | 6 | 83 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | chondroitin sulfotransferase activity | 2.53e-04 | 6 | 83 | 2 | GO:0034481 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | CACNA1B SLC13A1 RASA3 CACNA2D2 ATP2A1 ATP2A3 RYR1 RYR2 KCNH5 ITPR2 ITPR3 | 2.94e-04 | 758 | 83 | 11 | GO:0015318 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 2.95e-04 | 140 | 83 | 5 | GO:0099094 | |
| GeneOntologyMolecularFunction | channel activity | 3.28e-04 | 525 | 83 | 9 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 3.32e-04 | 526 | 83 | 9 | GO:0022803 | |
| GeneOntologyMolecularFunction | P-type calcium transporter activity | 9.16e-04 | 11 | 83 | 2 | GO:0005388 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 9.24e-04 | 46 | 83 | 3 | GO:0005245 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | 1.22e-03 | 507 | 83 | 8 | GO:0060589 | |
| GeneOntologyMolecularFunction | GTPase regulator activity | 1.22e-03 | 507 | 83 | 8 | GO:0030695 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 1.26e-03 | 193 | 83 | 5 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 1.38e-03 | 197 | 83 | 5 | GO:0022834 | |
| GeneOntologyMolecularFunction | inositol 1,4,5 trisphosphate binding | 1.50e-03 | 14 | 83 | 2 | GO:0070679 | |
| GeneOntologyMolecularFunction | enzyme activator activity | 1.59e-03 | 656 | 83 | 9 | GO:0008047 | |
| GeneOntologyMolecularFunction | MHC class Ib protein binding | 1.97e-03 | 16 | 83 | 2 | GO:0023029 | |
| GeneOntologyMolecularFunction | MHC class I receptor activity | 2.50e-03 | 18 | 83 | 2 | GO:0032393 | |
| GeneOntologyMolecularFunction | MHC class Ib receptor activity | 2.79e-03 | 19 | 83 | 2 | GO:0032394 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | CACNA1B PIEZO2 SLC13A1 RASA3 CACNA2D2 ATP2A1 ATP2A3 RYR1 RYR2 KCNH5 ITPR2 ITPR3 | 3.40e-03 | 1180 | 83 | 12 | GO:0022857 |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 3.72e-03 | 152 | 83 | 4 | GO:0022843 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 3.98e-03 | 614 | 83 | 8 | GO:0140657 | |
| GeneOntologyMolecularFunction | immune receptor activity | 4.98e-03 | 165 | 83 | 4 | GO:0140375 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 5.35e-03 | 85 | 83 | 3 | GO:0038024 | |
| GeneOntologyMolecularFunction | GTPase activator activity | 6.15e-03 | 279 | 83 | 5 | GO:0005096 | |
| GeneOntologyBiologicalProcess | maintenance of location | 4.25e-06 | 396 | 83 | 10 | GO:0051235 | |
| GeneOntologyBiologicalProcess | maintenance of location in cell | 9.71e-06 | 259 | 83 | 8 | GO:0051651 | |
| GeneOntologyBiologicalProcess | calcium ion homeostasis | 2.64e-05 | 389 | 83 | 9 | GO:0055074 | |
| GeneOntologyBiologicalProcess | chemical homeostasis | NPC1 TLCD1 CIB3 WFS1 PDK4 ANXA7 APOB DBH ATP2A1 ATP2A3 ADCY6 RYR1 RYR2 TFR2 ITPR2 ITPR3 | 3.26e-05 | 1249 | 83 | 16 | GO:0048878 |
| GeneOntologyBiologicalProcess | metal ion transport | CACNA1B SLC13A1 CACNA2D2 NETO1 WFS1 STEAP1B ATP2A1 ATP2A3 RYR1 RYR2 TFR2 KCNH5 ITPR2 ITPR3 | 4.20e-05 | 1000 | 83 | 14 | GO:0030001 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | CACNA1B PIEZO2 SLC13A1 CACNA2D2 NETO1 WFS1 STEAP1B ATP2A1 ATP2A3 RYR1 RYR2 TFR2 KCNH5 ITPR2 ITPR3 | 5.21e-05 | 1157 | 83 | 15 | GO:0006812 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | CACNA1B PIEZO2 SLC13A1 CACNA2D2 NETO1 STEAP1B ATP2A1 ATP2A3 RYR1 RYR2 KCNH5 ITPR2 ITPR3 | 9.42e-05 | 942 | 83 | 13 | GO:0098655 |
| GeneOntologyBiologicalProcess | regulation of acetyl-CoA biosynthetic process from pyruvate | 9.55e-05 | 4 | 83 | 2 | GO:0010510 | |
| GeneOntologyBiologicalProcess | intracellular calcium ion homeostasis | 9.87e-05 | 359 | 83 | 8 | GO:0006874 | |
| GeneOntologyBiologicalProcess | monoatomic cation homeostasis | CIB3 WFS1 PDK4 ANXA7 ATP2A1 ATP2A3 RYR1 RYR2 TFR2 ITPR2 ITPR3 | 1.18e-04 | 705 | 83 | 11 | GO:0055080 |
| GeneOntologyBiologicalProcess | monoatomic ion homeostasis | CIB3 WFS1 PDK4 ANXA7 ATP2A1 ATP2A3 RYR1 RYR2 TFR2 ITPR2 ITPR3 | 1.37e-04 | 717 | 83 | 11 | GO:0050801 |
| GeneOntologyBiologicalProcess | response to nitrogen compound | SEL1L NPC1 CACNA1B TBC1D4 WFS1 PDK4 ANXA7 DBH PLD2 ATP2A1 ADCY6 RYR1 RYR2 ITPR2 ITPR3 | 1.51e-04 | 1272 | 83 | 15 | GO:1901698 |
| GeneOntologyBiologicalProcess | regulation of acyl-CoA biosynthetic process | 1.59e-04 | 5 | 83 | 2 | GO:0050812 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | 1.80e-04 | 392 | 83 | 8 | GO:0070588 | |
| GeneOntologyBiologicalProcess | inorganic ion homeostasis | 1.94e-04 | 622 | 83 | 10 | GO:0098771 | |
| GeneOntologyBiologicalProcess | calcium ion transport | 2.06e-04 | 509 | 83 | 9 | GO:0006816 | |
| GeneOntologyBiologicalProcess | endoplasmic reticulum calcium ion homeostasis | 2.13e-04 | 29 | 83 | 3 | GO:0032469 | |
| GeneOntologyBiologicalProcess | regulation of cardiac conduction | 2.13e-04 | 29 | 83 | 3 | GO:1903779 | |
| GeneOntologyBiologicalProcess | positive regulation of ATPase-coupled calcium transmembrane transporter activity | 2.37e-04 | 6 | 83 | 2 | GO:1901896 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | CACNA1B SLC13A1 CACNA2D2 NETO1 STEAP1B ATP2A1 ATP2A3 RYR1 RYR2 KCNH5 ITPR2 ITPR3 | 3.08e-04 | 922 | 83 | 12 | GO:0098662 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | CACNA1B PIEZO2 SLC13A1 CACNA2D2 NETO1 WFS1 STEAP1B ATP2A1 ATP2A3 RYR1 RYR2 TFR2 KCNH5 ITPR2 ITPR3 | 3.47e-04 | 1374 | 83 | 15 | GO:0006811 |
| GeneOntologyBiologicalProcess | response to calcium ion | 4.84e-04 | 161 | 83 | 5 | GO:0051592 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | CACNA1B PIEZO2 SLC13A1 CACNA2D2 NETO1 STEAP1B ATP2A1 ATP2A3 RYR1 RYR2 KCNH5 ITPR2 ITPR3 | 4.88e-04 | 1115 | 83 | 13 | GO:0034220 |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane neurotransmitter receptor levels | 5.27e-04 | 164 | 83 | 5 | GO:0099072 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | SEL1L EPHX1 ATP8B3 RSAD2 TMED6 CYP2E1 HACD3 WFS1 SPTLC2 DIPK1A ANXA7 SEC11A ATL3 APOB FLRT3 DNAJC1 PLD2 ATP2A1 ATP2A3 RYR1 RYR2 ITPR2 ITPR3 | 6.66e-10 | 1293 | 83 | 23 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | SEL1L EPHX1 ATP8B3 RSAD2 TMED6 CYP2E1 HACD3 WFS1 SPTLC2 DIPK1A ANXA7 SEC11A ATL3 APOB FLRT3 DNAJC1 PLD2 ATP2A1 ATP2A3 RYR1 RYR2 ITPR2 ITPR3 | 7.28e-10 | 1299 | 83 | 23 | GO:0098827 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | SEL1L EPHX1 ATP8B3 RSAD2 TMED6 CYP2E1 HACD3 WFS1 SPTLC2 DIPK1A ANXA7 SEC11A ATL3 APOB FLRT3 DNAJC1 PLD2 ATP2A1 ATP2A3 RYR1 RYR2 ITPR2 ITPR3 | 1.10e-09 | 1327 | 83 | 23 | GO:0042175 |
| GeneOntologyCellularComponent | platelet dense tubular network membrane | 2.87e-08 | 9 | 83 | 4 | GO:0031095 | |
| GeneOntologyCellularComponent | platelet dense tubular network | 7.46e-08 | 11 | 83 | 4 | GO:0031094 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum membrane | 9.42e-07 | 45 | 83 | 5 | GO:0033017 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 1.36e-06 | 88 | 83 | 6 | GO:0016529 | |
| GeneOntologyCellularComponent | sarcoplasm | 6.18e-06 | 114 | 83 | 6 | GO:0016528 | |
| GeneOntologyCellularComponent | calcium channel complex | 1.06e-05 | 73 | 83 | 5 | GO:0034704 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | NPC1 ATP8B3 VAC14 TBC1D4 AP2A1 WFS1 VPS39 PI4KA ANXA7 APOB DBH KIR3DL1 KIR3DL2 ITPR2 ITPR3 | 1.75e-04 | 1307 | 83 | 15 | GO:0030659 |
| GeneOntologyCellularComponent | vesicle membrane | NPC1 ATP8B3 VAC14 TBC1D4 AP2A1 WFS1 VPS39 PI4KA ANXA7 APOB DBH KIR3DL1 KIR3DL2 ITPR2 ITPR3 | 2.03e-04 | 1325 | 83 | 15 | GO:0012506 |
| GeneOntologyCellularComponent | cytoplasmic side of membrane | 3.10e-04 | 230 | 83 | 6 | GO:0098562 | |
| GeneOntologyCellularComponent | cation channel complex | 3.47e-04 | 235 | 83 | 6 | GO:0034703 | |
| GeneOntologyCellularComponent | chromaffin granule membrane | 5.51e-04 | 9 | 83 | 2 | GO:0042584 | |
| GeneOntologyCellularComponent | junctional sarcoplasmic reticulum membrane | 6.87e-04 | 10 | 83 | 2 | GO:0014701 | |
| GeneOntologyCellularComponent | smooth endoplasmic reticulum | 8.10e-04 | 46 | 83 | 3 | GO:0005790 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 8.10e-04 | 46 | 83 | 3 | GO:0005891 | |
| GeneOntologyCellularComponent | cytoplasmic side of plasma membrane | 8.55e-04 | 185 | 83 | 5 | GO:0009898 | |
| GeneOntologyCellularComponent | chromaffin granule | 1.58e-03 | 15 | 83 | 2 | GO:0042583 | |
| GeneOntologyCellularComponent | filopodium tip | 2.83e-03 | 20 | 83 | 2 | GO:0032433 | |
| Domain | RIH_assoc | 5.40e-09 | 6 | 83 | 4 | PF08454 | |
| Domain | RIH_assoc-dom | 5.40e-09 | 6 | 83 | 4 | IPR013662 | |
| Domain | RIH_dom | 5.40e-09 | 6 | 83 | 4 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 5.40e-09 | 6 | 83 | 4 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 5.40e-09 | 6 | 83 | 4 | IPR015925 | |
| Domain | - | 5.40e-09 | 6 | 83 | 4 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 5.40e-09 | 6 | 83 | 4 | PF01365 | |
| Domain | Ins145_P3_rec | 5.40e-09 | 6 | 83 | 4 | PF08709 | |
| Domain | MIR | 7.46e-08 | 10 | 83 | 4 | PS50919 | |
| Domain | MIR | 7.46e-08 | 10 | 83 | 4 | PF02815 | |
| Domain | MIR | 7.46e-08 | 10 | 83 | 4 | SM00472 | |
| Domain | MIR_motif | 7.46e-08 | 10 | 83 | 4 | IPR016093 | |
| Domain | ARM-type_fold | VAC14 AP2A1 DOCK11 DOCK8 XPO6 IFT172 PI4KA MROH2A ASPM APOB ITPR2 | 3.02e-07 | 339 | 83 | 11 | IPR016024 |
| Domain | Hydrolase_3 | 9.93e-06 | 10 | 83 | 3 | PF08282 | |
| Domain | Ion_trans_dom | 1.17e-05 | 114 | 83 | 6 | IPR005821 | |
| Domain | Ion_trans | 1.17e-05 | 114 | 83 | 6 | PF00520 | |
| Domain | InsP3_rcpt-bd | 5.84e-05 | 3 | 83 | 2 | IPR000493 | |
| Domain | Ryanrecept_TM4-6 | 5.84e-05 | 3 | 83 | 2 | IPR009460 | |
| Domain | RyR | 5.84e-05 | 3 | 83 | 2 | PF02026 | |
| Domain | Ryanodine_rcpt | 5.84e-05 | 3 | 83 | 2 | IPR003032 | |
| Domain | RR_TM4-6 | 5.84e-05 | 3 | 83 | 2 | PF06459 | |
| Domain | P-type_ATPase_IIA | 5.84e-05 | 3 | 83 | 2 | IPR005782 | |
| Domain | Ryan_recept | 5.84e-05 | 3 | 83 | 2 | IPR013333 | |
| Domain | BCDHK_Adom3 | 1.93e-04 | 5 | 83 | 2 | PF10436 | |
| Domain | His_kinase_dom | 1.93e-04 | 5 | 83 | 2 | IPR005467 | |
| Domain | HIS_KIN | 1.93e-04 | 5 | 83 | 2 | PS50109 | |
| Domain | - | 1.93e-04 | 5 | 83 | 2 | 1.20.140.20 | |
| Domain | BCDHK/PDK_N | 1.93e-04 | 5 | 83 | 2 | IPR018955 | |
| Domain | DUF3398 | 2.89e-04 | 6 | 83 | 2 | PF11878 | |
| Domain | DOCK_C/D_N | 2.89e-04 | 6 | 83 | 2 | IPR021816 | |
| Domain | - | 3.82e-04 | 32 | 83 | 3 | 3.40.1110.10 | |
| Domain | - | 3.82e-04 | 32 | 83 | 3 | 2.70.150.10 | |
| Domain | Carb_sulfotransferase-rel | 4.04e-04 | 7 | 83 | 2 | IPR018011 | |
| Domain | ATPase_P-typ_cyto_domN | 5.00e-04 | 35 | 83 | 3 | IPR023299 | |
| Domain | Clathrin_H-chain/VPS_repeat | 5.37e-04 | 8 | 83 | 2 | IPR000547 | |
| Domain | P_typ_ATPase | 5.44e-04 | 36 | 83 | 3 | IPR001757 | |
| Domain | ATPase_P-typ_P_site | 5.44e-04 | 36 | 83 | 3 | IPR018303 | |
| Domain | ATPASE_E1_E2 | 5.44e-04 | 36 | 83 | 3 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 5.90e-04 | 37 | 83 | 3 | IPR008250 | |
| Domain | E1-E2_ATPase | 5.90e-04 | 37 | 83 | 3 | PF00122 | |
| Domain | TPR-like_helical_dom | 5.99e-04 | 233 | 83 | 6 | IPR011990 | |
| Domain | DOCK_C | 1.05e-03 | 11 | 83 | 2 | IPR010703 | |
| Domain | DHR-1_domain | 1.05e-03 | 11 | 83 | 2 | IPR027007 | |
| Domain | DHR_2 | 1.05e-03 | 11 | 83 | 2 | PS51651 | |
| Domain | DHR_1 | 1.05e-03 | 11 | 83 | 2 | PS51650 | |
| Domain | DOCK-C2 | 1.05e-03 | 11 | 83 | 2 | PF14429 | |
| Domain | DHR-2 | 1.05e-03 | 11 | 83 | 2 | IPR027357 | |
| Domain | DHR-2 | 1.05e-03 | 11 | 83 | 2 | PF06920 | |
| Domain | DOCK | 1.05e-03 | 11 | 83 | 2 | IPR026791 | |
| Domain | Sulfotransfer_2 | 1.25e-03 | 12 | 83 | 2 | PF03567 | |
| Domain | Sulfotransferase | 1.25e-03 | 12 | 83 | 2 | IPR005331 | |
| Domain | ARM-like | 1.29e-03 | 270 | 83 | 6 | IPR011989 | |
| Domain | - | 2.25e-03 | 16 | 83 | 2 | 1.20.1110.10 | |
| Domain | ATPase_P-typ_TM_dom | 2.25e-03 | 16 | 83 | 2 | IPR023298 | |
| Domain | - | 2.30e-03 | 207 | 83 | 5 | 1.25.40.10 | |
| Domain | ATPase_P-typ_cation-transptr_C | 2.54e-03 | 17 | 83 | 2 | IPR006068 | |
| Domain | Cation_ATPase_C | 2.54e-03 | 17 | 83 | 2 | PF00689 | |
| Domain | Cation_ATPase_N | 2.85e-03 | 18 | 83 | 2 | PF00690 | |
| Domain | Cation_ATPase_N | 2.85e-03 | 18 | 83 | 2 | SM00831 | |
| Domain | HATPase_c | 2.85e-03 | 18 | 83 | 2 | SM00387 | |
| Domain | HATPase_c | 3.18e-03 | 19 | 83 | 2 | PF02518 | |
| Domain | ATPase_P-typ_cation-transptr_N | 3.18e-03 | 19 | 83 | 2 | IPR004014 | |
| Domain | - | 3.52e-03 | 20 | 83 | 2 | 3.30.565.10 | |
| Domain | HATPase_C | 3.88e-03 | 21 | 83 | 2 | IPR003594 | |
| Domain | IQ | 3.89e-03 | 71 | 83 | 3 | PF00612 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 1.81e-07 | 54 | 66 | 6 | M27460 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 1.81e-07 | 54 | 66 | 6 | MM15202 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 4.95e-07 | 103 | 66 | 7 | MM15196 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.61e-06 | 19 | 66 | 4 | M47760 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 2.39e-06 | 130 | 66 | 7 | M27454 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 5.41e-06 | 147 | 66 | 7 | MM15854 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 6.46e-06 | 151 | 66 | 7 | M39329 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 7.09e-06 | 27 | 66 | 4 | MM15053 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 7.35e-06 | 154 | 66 | 7 | MM15974 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 8.00e-06 | 156 | 66 | 7 | M39475 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 8.24e-06 | 28 | 66 | 4 | M924 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 1.16e-05 | 165 | 66 | 7 | MM15026 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 1.57e-05 | 11 | 66 | 3 | M47958 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 1.89e-05 | 178 | 66 | 7 | M2890 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 2.76e-05 | 76 | 66 | 5 | MM15051 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SEL1L NPC1 ATP8B3 ARL2BP AP2A1 SLC13A1 APOB ATP2A1 ATP2A3 ADCY6 RYR1 RYR2 TFR2 | 3.02e-05 | 736 | 66 | 13 | M27287 |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 4.39e-05 | 203 | 66 | 7 | M5485 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 5.01e-05 | 86 | 66 | 5 | M916 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SEL1L NPC1 ATP8B3 ARL2BP AP2A1 SLC13A1 APOB ATP2A1 ATP2A3 RYR1 RYR2 TFR2 | 6.54e-05 | 681 | 66 | 12 | MM14985 |
| Pathway | REACTOME_LDL_CLEARANCE | 7.61e-05 | 18 | 66 | 3 | MM15565 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 7.61e-05 | 18 | 66 | 3 | M614 | |
| Pathway | REACTOME_LDL_CLEARANCE | 9.00e-05 | 19 | 66 | 3 | M27846 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 1.87e-04 | 61 | 66 | 4 | MM15071 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKN_TO_MGLUR1_SIGNALING_PATHWAY | 2.14e-04 | 5 | 66 | 2 | M49000 | |
| Pathway | WP_BENZENE_METABOLISM | 3.20e-04 | 6 | 66 | 2 | M39326 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_PLCD_ITPR_SIGNALING_PATHWAY | 3.20e-04 | 6 | 66 | 2 | M47960 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 3.55e-04 | 72 | 66 | 4 | MM14631 | |
| Pathway | WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY | 3.94e-04 | 74 | 66 | 4 | M48080 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 3.94e-04 | 74 | 66 | 4 | MM15962 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 4.82e-04 | 78 | 66 | 4 | M1921 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_CLEARANCE | 5.29e-04 | 34 | 66 | 3 | MM15566 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_SERCA | 5.94e-04 | 8 | 66 | 2 | M47955 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_CLEARANCE | 6.80e-04 | 37 | 66 | 3 | M27847 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BCR_PLCG_ITPR_SIGNALING_PATHWAY | 7.61e-04 | 9 | 66 | 2 | M47852 | |
| Pathway | REACTOME_DAG_AND_IP3_SIGNALING | 9.20e-04 | 41 | 66 | 3 | M512 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SPTBN2_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 9.48e-04 | 10 | 66 | 2 | M47661 | |
| Pathway | REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION | 9.88e-04 | 42 | 66 | 3 | M791 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 1.16e-03 | 11 | 66 | 2 | MM14498 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 1.16e-03 | 11 | 66 | 2 | M26913 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PRKCG_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 1.16e-03 | 11 | 66 | 2 | M49033 | |
| Pathway | REACTOME_CLEC7A_DECTIN_1_INDUCES_NFAT_ACTIVATION | 1.16e-03 | 11 | 66 | 2 | M27466 | |
| Pathway | KEGG_GNRH_SIGNALING_PATHWAY | 1.27e-03 | 101 | 66 | 4 | M1979 | |
| Pathway | WP_15Q25_COPY_NUMBER_VARIATION | 1.29e-03 | 46 | 66 | 3 | M48105 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 1.38e-03 | 12 | 66 | 2 | M27326 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 1.38e-03 | 176 | 66 | 5 | MM15718 | |
| Pathway | WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING | 1.63e-03 | 13 | 66 | 2 | M39589 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR1_TRPC3_SIGNALING_PATHWAY | 1.63e-03 | 13 | 66 | 2 | M47656 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.63e-03 | 13 | 66 | 2 | M47696 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_SIGMAR1_TO_CA2_APOPTOTIC_PATHWAY | 1.63e-03 | 13 | 66 | 2 | M47751 | |
| Pathway | KEGG_SULFUR_METABOLISM | 1.63e-03 | 13 | 66 | 2 | M18256 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 1.63e-03 | 13 | 66 | 2 | MM14553 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 1.63e-03 | 108 | 66 | 4 | M17034 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 1.64e-03 | 183 | 66 | 5 | M997 | |
| Pathway | WP_CILIOPATHIES | 1.68e-03 | 184 | 66 | 5 | M39880 | |
| Pathway | KEGG_TASTE_TRANSDUCTION | 1.84e-03 | 52 | 66 | 3 | M5785 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 1.89e-03 | 14 | 66 | 2 | MM15052 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 2.05e-03 | 54 | 66 | 3 | M26911 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 2.16e-03 | 55 | 66 | 3 | M971 | |
| Pathway | REACTOME_REGULATION_OF_PYRUVATE_DEHYDROGENASE_PDH_COMPLEX | 2.18e-03 | 15 | 66 | 2 | MM14820 | |
| Pathway | REACTOME_REGULATION_OF_PYRUVATE_DEHYDROGENASE_PDH_COMPLEX | 2.18e-03 | 15 | 66 | 2 | M716 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 2.39e-03 | 57 | 66 | 3 | MM15643 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 2.48e-03 | 16 | 66 | 2 | M26945 | |
| Pathway | WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION | 2.48e-03 | 16 | 66 | 2 | M40060 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE | 3.04e-03 | 62 | 66 | 3 | MM14686 | |
| Pathway | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE | 3.15e-03 | 18 | 66 | 2 | M645 | |
| Pathway | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE | 3.15e-03 | 18 | 66 | 2 | MM14642 | |
| Pathway | PID_ARF_3PATHWAY | 3.51e-03 | 19 | 66 | 2 | M243 | |
| Pathway | REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS | 3.51e-03 | 19 | 66 | 2 | MM14800 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_CELL_PROLIFERATION | 3.51e-03 | 19 | 66 | 2 | M27423 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TCR_PLCG_ITPR_SIGNALING_PATHWAY | 3.51e-03 | 19 | 66 | 2 | M47733 | |
| Pathway | REACTOME_SIGNALING_BY_HEDGEHOG | 3.86e-03 | 137 | 66 | 4 | MM15182 | |
| Pathway | REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS | 3.88e-03 | 20 | 66 | 2 | M658 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MACHR_CA2_APOPTOTIC_PATHWAY | 3.88e-03 | 20 | 66 | 2 | M47688 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MACHR_CA2_APOPTOTIC_PATHWAY | 4.28e-03 | 21 | 66 | 2 | M47689 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CARDIAC_TYPE_VGCC_RYR_SIGNALING | 4.28e-03 | 21 | 66 | 2 | M47950 | |
| Pathway | KEGG_MEDICUS_REFERENCE_SKELETAL_TYPE_VGCC_RYR_SIGNALING | 4.28e-03 | 21 | 66 | 2 | M47949 | |
| Pathway | KEGG_LONG_TERM_DEPRESSION | 4.29e-03 | 70 | 66 | 3 | M8232 | |
| Pathway | REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS | 4.50e-03 | 143 | 66 | 4 | M27107 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 4.69e-03 | 22 | 66 | 2 | M47690 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR5_CA2_APOPTOTIC_PATHWAY | 4.69e-03 | 22 | 66 | 2 | M47675 | |
| Pathway | KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_CHONDROITIN_SULFATE | 4.69e-03 | 22 | 66 | 2 | M19166 | |
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 4.29e-15 | 8 | 83 | 6 | 19033399 | |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 4.05e-12 | 38 | 83 | 7 | 30786075 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | SEL1L NPC1 EPHX1 VAC14 NPR3 TBC1D4 GTF3C1 HACD3 WFS1 SPTLC2 XPO6 DIPK1A ACKR3 SEC11A ENTPD6 LAMA1 CHST12 DNAJC1 ATP2A3 ITPR2 | 5.15e-12 | 1201 | 83 | 20 | 35696571 |
| Pubmed | 4.51e-10 | 6 | 83 | 4 | 23463619 | ||
| Pubmed | 4.51e-10 | 6 | 83 | 4 | 20519450 | ||
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 4.51e-10 | 6 | 83 | 4 | 25966694 | |
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 4.51e-10 | 6 | 83 | 4 | 16844763 | |
| Pubmed | 1.05e-09 | 7 | 83 | 4 | 11860456 | ||
| Pubmed | Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype. | 1.31e-08 | 3 | 83 | 3 | 11859120 | |
| Pubmed | Analysis of killer immunoglobulin-like receptor genes in ankylosing spondylitis. | 1.31e-08 | 3 | 83 | 3 | 19019897 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | SEL1L NPC1 VAC14 AP2A1 HACD3 WFS1 SPTLC2 XPO6 PI4KA EIF4A1 SEC11A TCF25 PEX11B ITPR3 | 4.85e-08 | 942 | 83 | 14 | 31073040 |
| Pubmed | Open conformers of HLA-F are high-affinity ligands of the activating NK-cell receptor KIR3DS1. | 5.23e-08 | 4 | 83 | 3 | 27455421 | |
| Pubmed | 5.23e-08 | 4 | 83 | 3 | 10828023 | ||
| Pubmed | 5.23e-08 | 4 | 83 | 3 | 9384575 | ||
| Pubmed | 5.23e-08 | 4 | 83 | 3 | 19120137 | ||
| Pubmed | NPC1 GTF3C1 AP2A1 DOCK8 MYO9B PI4KA EIF4A1 ANXA7 ATL3 CHST12 DNAJC1 PEX11B ITPR2 ITPR3 | 6.55e-07 | 1168 | 83 | 14 | 19946888 | |
| Pubmed | 7.28e-07 | 8 | 83 | 3 | 11784029 | ||
| Pubmed | 7.28e-07 | 8 | 83 | 3 | 9430221 | ||
| Pubmed | Alternatively spliced forms of human killer inhibitory receptors. | 1.09e-06 | 9 | 83 | 3 | 8662091 | |
| Pubmed | A micropeptide encoded by a putative long noncoding RNA regulates muscle performance. | 1.09e-06 | 9 | 83 | 3 | 25640239 | |
| Pubmed | 1.55e-06 | 10 | 83 | 3 | 18434328 | ||
| Pubmed | 1.67e-06 | 150 | 83 | 6 | 32423001 | ||
| Pubmed | [Polymorphism of killer cell immunoglobulin-like receptor gene and its correlation with leukemia]. | 2.84e-06 | 12 | 83 | 3 | 17490516 | |
| Pubmed | 2.84e-06 | 12 | 83 | 3 | 20137308 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | SEL1L GTF3C1 AP2A1 HACD3 SPTLC2 IFT172 SEC11A ATL3 PLD2 ATP2A1 PTPN20 ITPR3 | 3.39e-06 | 974 | 83 | 12 | 28675297 |
| Pubmed | 4.21e-06 | 176 | 83 | 6 | 28692057 | ||
| Pubmed | 4.68e-06 | 14 | 83 | 3 | 19875891 | ||
| Pubmed | Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population. | 4.68e-06 | 14 | 83 | 3 | 15896204 | |
| Pubmed | 4.68e-06 | 14 | 83 | 3 | 19489269 | ||
| Pubmed | 4.68e-06 | 14 | 83 | 3 | 18945962 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 23524032 | ||
| Pubmed | Diversity of the p70 killer cell inhibitory receptor (KIR3DL) family members in a single individual. | 5.63e-06 | 2 | 83 | 2 | 10774747 | |
| Pubmed | Isoform diversity of the inositol trisphosphate receptor in cell types of mouse origin. | 5.63e-06 | 2 | 83 | 2 | 9065779 | |
| Pubmed | Expression of IP3 receptor isoforms at the nodes of Ranvier in rat sciatic nerve. | 5.63e-06 | 2 | 83 | 2 | 17496801 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 30365992 | ||
| Pubmed | No association of KIR3DL1 or KIR3DS1 or their alleles with ankylosing spondylitis. | 5.63e-06 | 2 | 83 | 2 | 19874556 | |
| Pubmed | Functional polymorphism of the KIR3DL1/S1 receptor on human NK cells. | 5.63e-06 | 2 | 83 | 2 | 17182560 | |
| Pubmed | Mice lacking inositol 1,4,5-trisphosphate receptors exhibit dry eye. | 5.63e-06 | 2 | 83 | 2 | 24901844 | |
| Pubmed | Evaluation of KIR3DL1/KIR3DS1 polymorphism in Behçet's disease. | 5.63e-06 | 2 | 83 | 2 | 27708262 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 19008943 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 33854148 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 28158491 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 17259277 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 11207248 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 21228414 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 19528657 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 18331531 | ||
| Pubmed | Ryanodine receptor oligomeric interaction: identification of a putative binding region. | 5.63e-06 | 2 | 83 | 2 | 14722100 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 16805919 | ||
| Pubmed | Structural and functional interactions within ryanodine receptor. | 5.63e-06 | 2 | 83 | 2 | 26009179 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 8063813 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 19386717 | ||
| Pubmed | Cloning and characterization of human type 2 and type 3 inositol 1,4,5-trisphosphate receptors. | 5.63e-06 | 2 | 83 | 2 | 8081734 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 32899693 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 12606813 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 24285081 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 19211742 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 28942035 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 20230527 | ||
| Pubmed | Allele imputation for the killer cell immunoglobulin-like receptor KIR3DL1/S1. | 5.63e-06 | 2 | 83 | 2 | 35192601 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 11098931 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 30542613 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 18586264 | ||
| Pubmed | IP3 receptor types 2 and 3 mediate exocrine secretion underlying energy metabolism. | 5.63e-06 | 2 | 83 | 2 | 16195467 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 37647275 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 20131260 | ||
| Pubmed | Mitochondrial calcium overload is a key determinant in heart failure. | 5.63e-06 | 2 | 83 | 2 | 26217001 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 15280431 | ||
| Pubmed | Expression of the ryanodine receptor isoforms in immune cells. | 5.63e-06 | 2 | 83 | 2 | 11673493 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 11673462 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 25112829 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 22156006 | ||
| Pubmed | Life style, environmental and genetic susceptibility to cervical cancer. | 5.63e-06 | 2 | 83 | 2 | 15138035 | |
| Pubmed | Unusual selection on the KIR3DL1/S1 natural killer cell receptor in Africans. | 5.63e-06 | 2 | 83 | 2 | 17694054 | |
| Pubmed | Common allosteric mechanisms between ryanodine and inositol-1,4,5-trisphosphate receptors. | 5.63e-06 | 2 | 83 | 2 | 21150295 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 15632133 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 15713744 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 18936250 | ||
| Pubmed | Meiotic recombination generates rich diversity in NK cell receptor genes, alleles, and haplotypes. | 5.63e-06 | 2 | 83 | 2 | 19411600 | |
| Pubmed | Crystal structures of wild type and disease mutant forms of the ryanodine receptor SPRY2 domain. | 5.63e-06 | 2 | 83 | 2 | 25370123 | |
| Pubmed | Ryanodine receptors in human pancreatic beta cells: localization and effects on insulin secretion. | 5.63e-06 | 2 | 83 | 2 | 15033925 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 18622027 | ||
| Pubmed | Contribution of functional KIR3DL1 to ankylosing spondylitis. | 5.63e-06 | 2 | 83 | 2 | 20818412 | |
| Pubmed | Thermodynamics of calmodulin binding to cardiac and skeletal muscle ryanodine receptor ion channels. | 5.63e-06 | 2 | 83 | 2 | 18618700 | |
| Pubmed | KIR3DL1 and KIR3DL2 gene copy number variation in axial spondyloarthritis. | 5.63e-06 | 2 | 83 | 2 | 25940819 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 8777725 | ||
| Pubmed | 5.84e-06 | 15 | 83 | 3 | 20082646 | ||
| Pubmed | 5.84e-06 | 15 | 83 | 3 | 19926642 | ||
| Pubmed | 5.84e-06 | 15 | 83 | 3 | 20356536 | ||
| Pubmed | 5.84e-06 | 15 | 83 | 3 | 20643584 | ||
| Pubmed | 5.84e-06 | 15 | 83 | 3 | 19326408 | ||
| Pubmed | 7.18e-06 | 16 | 83 | 3 | 19897003 | ||
| Pubmed | 7.18e-06 | 16 | 83 | 3 | 19000141 | ||
| Pubmed | 7.18e-06 | 16 | 83 | 3 | 20670355 | ||
| Pubmed | Activating killer cell immunoglobulin-like receptor genes' association with recurrent miscarriage. | 7.18e-06 | 16 | 83 | 3 | 19527230 | |
| Pubmed | 7.18e-06 | 16 | 83 | 3 | 20652381 | ||
| Pubmed | 7.18e-06 | 16 | 83 | 3 | 18668235 | ||
| Pubmed | 7.18e-06 | 16 | 83 | 3 | 19279038 | ||
| Pubmed | 7.18e-06 | 16 | 83 | 3 | 17868255 | ||
| Pubmed | 7.18e-06 | 16 | 83 | 3 | 18643961 | ||
| Interaction | EVA1C interactions | 6.72e-06 | 65 | 82 | 5 | int:EVA1C | |
| Interaction | ATP2A1 interactions | TLCD1 AP2A1 HACD3 WFS1 SPTLC2 DNAJC1 ATP2A1 ATP2A3 ITPR2 ITPR3 | 8.30e-06 | 423 | 82 | 10 | int:ATP2A1 |
| Interaction | DERL1 interactions | SEL1L EPHX1 AP2A1 HACD3 SPTLC2 TCF25 APOB DNAJC1 ITPR2 ITPR3 | 1.50e-05 | 453 | 82 | 10 | int:DERL1 |
| Interaction | LMBR1L interactions | SEL1L NPC1 VAC14 AP2A1 HACD3 WFS1 SPTLC2 XPO6 PI4KA EIF4A1 SEC11A TCF25 PEX11B ITPR3 | 2.56e-05 | 946 | 82 | 14 | int:LMBR1L |
| Interaction | C3orf52 interactions | 3.39e-05 | 305 | 82 | 8 | int:C3orf52 | |
| Interaction | C5AR1 interactions | 3.92e-05 | 154 | 82 | 6 | int:C5AR1 | |
| Interaction | CHRNB2 interactions | 6.32e-05 | 103 | 82 | 5 | int:CHRNB2 | |
| GeneFamily | CD molecules|Killer cell immunoglobulin like receptors | 1.67e-05 | 18 | 51 | 3 | 620 | |
| GeneFamily | Inositol 1,4,5-triphosphate receptors|Protein phosphatase 1 regulatory subunits | 2.34e-05 | 3 | 51 | 2 | 297 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 2.34e-05 | 3 | 51 | 2 | 287 | |
| GeneFamily | ATPases Ca2+ transporting | 2.77e-04 | 9 | 51 | 2 | 1209 | |
| GeneFamily | Intraflagellar transport proteins|Tetratricopeptide repeat domain containing | 2.07e-03 | 24 | 51 | 2 | 615 | |
| GeneFamily | Calcium voltage-gated channel subunits | 2.43e-03 | 26 | 51 | 2 | 253 | |
| GeneFamily | Sulfotransferases, membrane bound | 4.88e-03 | 37 | 51 | 2 | 763 | |
| Coexpression | GSE339_CD8POS_VS_CD4CD8DN_DC_DN | 3.45e-06 | 200 | 83 | 7 | M5118 | |
| Coexpression | GSE32255_WT_VS_JMJD2D_KNOCKDOWN_4H_LPS_STIM_DC_UP | 1.01e-05 | 155 | 83 | 6 | M8913 | |
| Coexpression | RIGGI_EWING_SARCOMA_PROGENITOR_DN | 3.79e-05 | 196 | 83 | 6 | M13256 | |
| Coexpression | GSE22886_IL2_VS_IL15_STIM_NKCELL_UP | 3.79e-05 | 196 | 83 | 6 | M4514 | |
| Coexpression | GSE4142_GC_BCELL_VS_MEMORY_BCELL_UP | 4.24e-05 | 200 | 83 | 6 | M6397 | |
| Coexpression | HASLINGER_B_CLL_WITH_17P13_DELETION | 4.51e-05 | 22 | 83 | 3 | M3256 | |
| Coexpression | SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 | 6.83e-05 | 318 | 83 | 7 | M2429 | |
| Coexpression | GSE6269_FLU_VS_E_COLI_INF_PBMC_UP | 1.77e-04 | 164 | 83 | 5 | M5653 | |
| Coexpression | GSE3565_CTRL_VS_LPS_INJECTED_DUSP1_KO_SPLENOCYTES_DN | 2.15e-04 | 171 | 83 | 5 | M6321 | |
| Coexpression | CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP | 2.22e-04 | 385 | 83 | 7 | M2840 | |
| Coexpression | CHEN_METABOLIC_SYNDROM_NETWORK | CYP2E1 RASA3 DOCK11 DOCK8 MYO9B WFS1 SPTLC2 MYO1F CHST12 DBH STEAP1B ADCY6 ITPR3 | 2.42e-04 | 1316 | 83 | 13 | MM1052 |
| Coexpression | MOOTHA_PYR | 2.74e-04 | 8 | 83 | 2 | M5871 | |
| Coexpression | REN_ALVEOLAR_RHABDOMYOSARCOMA_UP | 2.80e-04 | 99 | 83 | 4 | M768 | |
| Coexpression | LIU_PROSTATE_CANCER_UP | 2.80e-04 | 99 | 83 | 4 | M4619 | |
| Coexpression | LI_ESTROGENE_BIDIRECTIONAL_E2_RESPONSE | 2.91e-04 | 100 | 83 | 4 | M48225 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | 3.03e-04 | 681 | 83 | 9 | M5314 | |
| Coexpression | E2F1_UP.V1_DN | 3.24e-04 | 187 | 83 | 5 | M2630 | |
| Coexpression | TSUTSUMI_FBXW8_TARGETS | 3.52e-04 | 9 | 83 | 2 | MM888 | |
| Coexpression | TSUTSUMI_FBXW8_TARGETS | 3.52e-04 | 9 | 83 | 2 | M2187 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | 3.83e-04 | 703 | 83 | 9 | MM1055 | |
| Coexpression | GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_20MIN_UP | 3.93e-04 | 195 | 83 | 5 | M6899 | |
| Coexpression | GSE11864_CSF1_IFNG_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP | 4.12e-04 | 197 | 83 | 5 | M3144 | |
| Coexpression | GSE7460_TREG_VS_TCONV_ACT_DN | 4.12e-04 | 197 | 83 | 5 | M5691 | |
| Coexpression | GSE22886_IGG_IGA_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_DN | 4.21e-04 | 198 | 83 | 5 | M4446 | |
| Coexpression | GSE14308_TH17_VS_NAIVE_CD4_TCELL_DN | 4.31e-04 | 199 | 83 | 5 | M3384 | |
| Coexpression | GSE13522_CTRL_VS_T_CRUZI_G_STRAIN_INF_SKIN_UP | 4.31e-04 | 199 | 83 | 5 | M2922 | |
| Coexpression | GSE7460_WT_VS_FOXP3_HET_ACT_TCONV_UP | 4.31e-04 | 199 | 83 | 5 | M5709 | |
| Coexpression | GSE40277_GATA1_AND_SATB1_TRANSDUCED_VS_CTRL_CD4_TCELL_DN | 4.31e-04 | 199 | 83 | 5 | M9178 | |
| Coexpression | GSE2197_IMMUNOSUPPRESSIVE_DNA_VS_UNTREATEDIN_DC_DN | 4.31e-04 | 199 | 83 | 5 | M4390 | |
| Coexpression | PARENT_MTOR_SIGNALING_UP | 4.34e-04 | 567 | 83 | 8 | M16909 | |
| Coexpression | UNTERMAN_IPF_VS_CTRL_NK_CELL_DN | 4.39e-04 | 10 | 83 | 2 | M48288 | |
| Coexpression | GSE339_CD4POS_VS_CD8POS_DC_UP | 4.41e-04 | 200 | 83 | 5 | M5108 | |
| Coexpression | GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_KO_LIVER_UP | 4.41e-04 | 200 | 83 | 5 | M5973 | |
| Coexpression | GSE369_PRE_VS_POST_IL6_INJECTION_SOCS3_KO_LIVER_DN | 4.41e-04 | 200 | 83 | 5 | M5977 | |
| Coexpression | GSE19401_UNSTIM_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_UP | 4.41e-04 | 200 | 83 | 5 | M7665 | |
| Coexpression | GSE8685_IL2_ACT_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_UP | 4.41e-04 | 200 | 83 | 5 | M331 | |
| Coexpression | GSE24026_PD1_LIGATION_VS_CTRL_IN_ACT_TCELL_LINE_DN | 4.41e-04 | 200 | 83 | 5 | M4538 | |
| Coexpression | GSE15330_GRANULOCYTE_MONOCYTE_PROGENITOR_VS_PRO_BCELL_DN | 4.41e-04 | 200 | 83 | 5 | M7042 | |
| Coexpression | HALLMARK_XENOBIOTIC_METABOLISM | 4.41e-04 | 200 | 83 | 5 | M5934 | |
| Coexpression | GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_UP | 4.41e-04 | 200 | 83 | 5 | M6524 | |
| Coexpression | GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_UP | 4.41e-04 | 200 | 83 | 5 | M6558 | |
| Coexpression | GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_UP | 4.41e-04 | 200 | 83 | 5 | M6514 | |
| Coexpression | GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_WT_CD4_TCELL_DN | 4.41e-04 | 200 | 83 | 5 | M9887 | |
| Coexpression | GSE18893_CTRL_VS_TNF_TREATED_TCONV_2H_DN | 4.41e-04 | 200 | 83 | 5 | M7302 | |
| Coexpression | GSE34392_ST2_KO_VS_WT_DAY8_LCMV_EFFECTOR_CD8_TCELL_UP | 4.41e-04 | 200 | 83 | 5 | M8653 | |
| Coexpression | GSE43863_TH1_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_DN | 4.41e-04 | 200 | 83 | 5 | M9768 | |
| Coexpression | GSE38304_MYC_NEG_VS_POS_GC_BCELL_UP | 4.41e-04 | 200 | 83 | 5 | M9273 | |
| Coexpression | GSE40274_FOXP3_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | 4.41e-04 | 200 | 83 | 5 | M9186 | |
| Coexpression | KAECH_NAIVE_VS_MEMORY_CD8_TCELL_UP | 4.41e-04 | 200 | 83 | 5 | M3020 | |
| Coexpression | GSE20715_0H_VS_48H_OZONE_TLR4_KO_LUNG_UP | 4.41e-04 | 200 | 83 | 5 | M4379 | |
| Coexpression | GOLDRATH_NAIVE_VS_MEMORY_CD8_TCELL_UP | 4.41e-04 | 200 | 83 | 5 | M3038 | |
| Coexpression | GOLDRATH_NAIVE_VS_EFF_CD8_TCELL_UP | 4.41e-04 | 200 | 83 | 5 | M3035 | |
| Coexpression | GSE36009_WT_VS_NLRP10_KO_DC_UP | 4.41e-04 | 200 | 83 | 5 | M8775 | |
| Coexpression | SMIRNOV_RESPONSE_TO_IR_6HR_DN | 4.79e-04 | 114 | 83 | 4 | M2590 | |
| Coexpression | CHEN_METABOLIC_SYNDROM_NETWORK | CYP2E1 RASA3 DOCK11 DOCK8 MYO9B WFS1 SPTLC2 MYO1F CHST12 DBH ADCY6 ITPR3 | 5.24e-04 | 1242 | 83 | 12 | M1920 |
| CoexpressionAtlas | ratio_StemCell_vs_induced-Ectoderm_top-relative-expression-ranked_2500_k-means-cluster#1 | ATP8B3 PSTK RSAD2 OTULIN KBTBD6 CIB3 SPTLC2 MYO1F SMARCA2 ATP2A3 TFR2 ITPR2 CHST13 | 3.01e-06 | 717 | 81 | 13 | ratio_SC_vs_ECTO_2500_K1 |
| CoexpressionAtlas | ratio_StemCell_vs_induced-Ectoderm_top-relative-expression-ranked_1000 | EPHX1 ATP8B3 TLCD1 NETO1 SPTLC2 MYO1F SMARCA2 ATP2A3 RYR1 RYR2 TFR2 DNAH11 ITPR2 ITPR3 CHST13 | 4.05e-06 | 984 | 81 | 15 | PCBC_ratio_SC_vs_ECTO_1000 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.01e-08 | 184 | 82 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.01e-08 | 184 | 82 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.01e-08 | 184 | 82 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | nucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-NK|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.49e-06 | 192 | 82 | 6 | a06d5d3c2537f8d2b1dc6b6f3e88a80b5c2a1850 | |
| ToppCell | Control-Myeloid-Monocyte-derived_macrophages|Control / group, cell type (main and fine annotations) | 1.54e-06 | 193 | 82 | 6 | a6b3bd01e585e2e3fbe9bf693a2e385773123f8e | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.59e-06 | 194 | 82 | 6 | bc7c4efe2a82057fb95582da983e36f413990902 | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-NK|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 1.79e-06 | 198 | 82 | 6 | e39ef71f3a9e0591bc0300ae132036fe2f8d5716 | |
| ToppCell | normal_Lung-T/NK_cells-NK|T/NK_cells / Location, Cell class and cell subclass | 1.84e-06 | 199 | 82 | 6 | 407ae8575bb4dec7fe10d48ceb8f32a03f5ac1bb | |
| ToppCell | distal-3-Hematologic-Natural_Killer|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.89e-06 | 200 | 82 | 6 | ea11ace5d540c02f23242e48e4d0d7d54999af0e | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-CD8_low_T|T/NK_cells / Location, Cell class and cell subclass | 8.01e-06 | 148 | 82 | 5 | db046a02a00829910bf9d7dbda068e730aa78f00 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2.Synpr-Sncg_(Neuron.Gad1Gad2.Synpr-Sncg)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 8.09e-06 | 69 | 82 | 4 | 9778ec48eceef5bd6f59b5b55ca4a6cc348a1eba | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2.Synpr-Sncg_(Neuron.Gad1Gad2.Synpr-Sncg)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 8.09e-06 | 69 | 82 | 4 | 8c4c4e2cd4c319adbe44fa2bcb5bb5cd5d81a2fd | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c2-CXCR4(low)|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.83e-06 | 151 | 82 | 5 | b698ddc74565d47892c09c3f16d78038da2dd5e7 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.03e-05 | 156 | 82 | 5 | f5889a6899904dfb7f596600b3a76857cf9d5378 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 1.28e-05 | 163 | 82 | 5 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_B2|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.28e-05 | 163 | 82 | 5 | 036e65de0f8fc391f3e4d299bf4c05ee5c3b5a37 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-05 | 167 | 82 | 5 | 0130743084dbcb20e10f96715d30961122150cbf | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B-Plasma_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-05 | 167 | 82 | 5 | 7bcae3797d3a0811e7f39885afdfd29ec517f11b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B-Plasma_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-05 | 167 | 82 | 5 | c6f0209a1ad797631fdfa3efab6db6b1d3e8e315 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-T_cells-TRGV2_gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.70e-05 | 173 | 82 | 5 | 79d11f94a8f6a420c18c2fef0da77e9af3204765 | |
| ToppCell | Control-B_cells|Control / group, cell type (main and fine annotations) | 1.85e-05 | 176 | 82 | 5 | 9125caa27bf790f6b1b960a86c09b4bcb1b58641 | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-T_NK-gdT|Multiple_Sclerosis / Disease, Lineage and Cell Type | 2.01e-05 | 179 | 82 | 5 | ab8d8104b38603ec7fbc5b35d7149e71ad57c43a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.06e-05 | 180 | 82 | 5 | cfc8bfbfd3617aabbb49f9730c29b673ca157e74 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.12e-05 | 181 | 82 | 5 | 6cdee2f56bc633b387b4dbbd78c624edbd712c24 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.12e-05 | 181 | 82 | 5 | b75b8b025257bccfe661fd0f92ab284b2a9c12ee | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.12e-05 | 181 | 82 | 5 | 5a4fe0eca7cbc9cbc8a2fdbe795a7c5f4052a659 | |
| ToppCell | COVID-19-B_cells-Plasma_cells|COVID-19 / group, cell type (main and fine annotations) | 2.23e-05 | 183 | 82 | 5 | 130c109f63a5e3c8f83cb96e32f4addf513b6415 | |
| ToppCell | COVID-19-B_cells|COVID-19 / group, cell type (main and fine annotations) | 2.23e-05 | 183 | 82 | 5 | 2c016bb59f131a0e821853b085289a3583f0a729 | |
| ToppCell | COVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type | 2.29e-05 | 184 | 82 | 5 | 51ed1ebfdef45149541917c66cbacad87072e51f | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_int|lung / Disease (COVID-19 only), tissue and cell type | 2.29e-05 | 184 | 82 | 5 | 480595a0e2e6aa2a77b7daa36490ae3af3d8dfee | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_A|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.35e-05 | 185 | 82 | 5 | 25781cf68e693e97dc1885e2879ab24fa946b51e | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|lung / Disease (COVID-19 only), tissue and cell type | 2.41e-05 | 186 | 82 | 5 | 66676d9395172de5707e204826a1c9f73b448cca | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_int|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.54e-05 | 188 | 82 | 5 | 599195338070ac6b79bd114609d9e10cac4f1df4 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_NK-natural_killer_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.54e-05 | 188 | 82 | 5 | a29c43a91ed1364a09d5abab6efa51b8061bce74 | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.54e-05 | 188 | 82 | 5 | 567b08514d9d84cbb40f9b7a679eec304f023428 | |
| ToppCell | COVID-19-T_cells-NK_cells|COVID-19 / group, cell type (main and fine annotations) | 2.60e-05 | 189 | 82 | 5 | b699152dfbb8cd8ed724e1e5a51838f29b681b62 | |
| ToppCell | megakaryocytic-CD34+_Megakaryoblast|World / Lineage and Cell class | 2.67e-05 | 190 | 82 | 5 | 1d19b2bd55789bf13e1386332f46c605973d6f8e | |
| ToppCell | RV-08._Macrophage|World / Chamber and Cluster_Paper | 2.81e-05 | 192 | 82 | 5 | a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_NK-T_NK-mature_NK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.81e-05 | 192 | 82 | 5 | e48bbcb97c113f323ad4db96bd10d593b9206923 | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-NK|normal_Pleural_Fluid / Location, Cell class and cell subclass | 2.81e-05 | 192 | 82 | 5 | 59dd4f5ae9f1cca78adf60b71661092ef09e6641 | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.81e-05 | 192 | 82 | 5 | 1922b0350d3375e67c314dbce8074e5cf986f2ef | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.81e-05 | 192 | 82 | 5 | 97c197643e59835c6d45dde9e549c9a1b1bb7288 | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.81e-05 | 192 | 82 | 5 | a4d161e3d48bc020e687808b352325ef9d1cc1f3 | |
| ToppCell | RV-08._Macrophage|RV / Chamber and Cluster_Paper | 2.88e-05 | 193 | 82 | 5 | 12bf98a280f87e4d8f0c6887dfc855da72e47ac1 | |
| ToppCell | BLOOD--(1)_EM_CTLs| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.95e-05 | 194 | 82 | 5 | 66583c6cff3814902d6babdea3a2ae962decde65 | |
| ToppCell | COVID-19-lung-NK_cells|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.95e-05 | 194 | 82 | 5 | 4c92f18e0a34fb50630d4b260eaf179202508b6d | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.95e-05 | 194 | 82 | 5 | fa72c2f3e6b8bfc2ef126deb219ec6a44809385b | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD8-Tem/emra_CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.95e-05 | 194 | 82 | 5 | ecdfc27d06e363fb23f0309f26ef6404a89f14ec | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.95e-05 | 194 | 82 | 5 | 4dfc890bacf133cfb6ec7c8b73f084f2491cf78e | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.95e-05 | 194 | 82 | 5 | b43788e458a80ab93f485f4577370aec448ad95e | |
| ToppCell | IIF-Lymphocyte-T_NK-NK|IIF / Disease, Lineage and Cell Type | 3.02e-05 | 195 | 82 | 5 | 464ce05cb52f78aee22d3baa6641b37bd53aae16 | |
| ToppCell | BLOOD--(1)_T_cell-(1)_EM_CTLs|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.02e-05 | 195 | 82 | 5 | 7df67ad5c62235474ee56ea07a957253d45f066b | |
| ToppCell | COVID-19-lung-NK_cells|lung / Disease (COVID-19 only), tissue and cell type | 3.02e-05 | 195 | 82 | 5 | 3b716ec7acc9a37af6bf40e711a539ce58d74aa4 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_NK|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.02e-05 | 195 | 82 | 5 | acc603dc94ac6518adb0dffb43305b380ec75b52 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_NK-NK_CD16|lymph-node_spleen / Manually curated celltypes from each tissue | 3.02e-05 | 195 | 82 | 5 | e756733cf48768bf40058d6cf9039e52f7563133 | |
| ToppCell | T/NK_cells-CD56dim_NK_cell|World / Lineage and Cell class | 3.02e-05 | 195 | 82 | 5 | 6124e87cb9061bf8918377fb4a79084079ddfc16 | |
| ToppCell | normal-na-Lymphocytic_NK|normal / PBMC cell types (v2) per disease, treatment status, and sex | 3.02e-05 | 195 | 82 | 5 | cebe79c42af5910353ba9ad7d0edb01982f772a3 | |
| ToppCell | LAM-Lymphoid-NK|LAM / Condition, Lineage and Cell class | 3.02e-05 | 195 | 82 | 5 | 229374c72acef32b0e915379bdf3c82f351940e2 | |
| ToppCell | (0)_NK_cells|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.10e-05 | 196 | 82 | 5 | 9b080859130cf156bfa833dc71fd39734cb9a32d | |
| ToppCell | CV-Moderate-1|Moderate / Virus stimulation, Condition and Cluster | 3.10e-05 | 196 | 82 | 5 | b50cfcd87c5b67806450cb8b3c6860ab97f6d3b1 | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-NK|metastatic_Lymph_Node / Location, Cell class and cell subclass | 3.10e-05 | 196 | 82 | 5 | f69f53e2ac1818b4ad0161b0bd70655e98ef65f0 | |
| ToppCell | (0)_NK|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.10e-05 | 196 | 82 | 5 | e2578a562d9903a33a7c60db229005680af8141c | |
| ToppCell | normal-na-Lymphocytic_NK-NK_dim-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 3.10e-05 | 196 | 82 | 5 | 61bc0d161e01f36e5bcda4d4f4693afbfe5654bb | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_NK-NK_CD16|lymph-node_spleen / Manually curated celltypes from each tissue | 3.10e-05 | 196 | 82 | 5 | f7e5a7fad4547e8ab9ab8b140239281832fb4260 | |
| ToppCell | tumor_Lung-T/NK_cells-NK|tumor_Lung / Location, Cell class and cell subclass | 3.10e-05 | 196 | 82 | 5 | 006e630f3d8033f45c6b7e9154d77000c7b0cb70 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_NK-NK_dim-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.10e-05 | 196 | 82 | 5 | c25f90c4e5abfe7cfaa85bfe136c438a5179c978 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_NK-NK_dim|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.10e-05 | 196 | 82 | 5 | d451f279f4086fcf727af712f98923551181c76e | |
| ToppCell | normal-na-Lymphocytic_NK-NK_dim|normal / PBMC cell types (v2) per disease, treatment status, and sex | 3.10e-05 | 196 | 82 | 5 | 3360d96dc06241498995bcb875615bd4c1424f5a | |
| ToppCell | normal_Lung-T/NK_cells-NK|normal_Lung / Location, Cell class and cell subclass | 3.18e-05 | 197 | 82 | 5 | 6045a05a5f1073d683806eb46a3fa98358414625 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_NK-NK_dim-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.18e-05 | 197 | 82 | 5 | 76304df40f87224f8e415677e3ee8fb183fe0c03 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-Macrophages|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.18e-05 | 197 | 82 | 5 | 10190b877bf46ba2163d203df9dd3b498c66e52f | |
| ToppCell | CV-Moderate-1|CV / Virus stimulation, Condition and Cluster | 3.18e-05 | 197 | 82 | 5 | e3d00d850b4d191f9592ef993c0eaadfe5710b5f | |
| ToppCell | T/NK_cells-CD56dim_NK_cell|T/NK_cells / Lineage and Cell class | 3.18e-05 | 197 | 82 | 5 | 722d00a218755cc8cb7b5ab2a7fca40269247c3a | |
| ToppCell | tumor_Lung-T/NK_cells-NK|T/NK_cells / Location, Cell class and cell subclass | 3.18e-05 | 197 | 82 | 5 | e9fac2c923179b2b8b0500076421c6fb09960b56 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_B|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.18e-05 | 197 | 82 | 5 | d2f7ba404a0340e12ccbd3f9d76c8d782584e775 | |
| ToppCell | Transverse-(5)_Dendritic_cell-(53)_Lymphoid_DC|Transverse / shred on region, Cell_type, and subtype | 3.18e-05 | 197 | 82 | 5 | 15b87fd3906d7388c271d30d0c64b1bcc490801c | |
| ToppCell | Transverse-Dendritic_cell-Lymphoid_DC|Transverse / Region, Cell class and subclass | 3.18e-05 | 197 | 82 | 5 | a58af0ea82f76f2a7abac1f62629ff20d552fc63 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class | 3.25e-05 | 198 | 82 | 5 | 76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7 | |
| ToppCell | mild_COVID-19_(asymptomatic)-NK|World / disease group, cell group and cell class (v2) | 3.25e-05 | 198 | 82 | 5 | 7a0aac52d785037455e068e1b25de4b2bf0fff79 | |
| ToppCell | (0)_NK_FCGR3Apos|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 3.25e-05 | 198 | 82 | 5 | 13f10f9233fc1523f0da2d9d59f3ced9c51a603a | |
| ToppCell | Fetal_29-31_weeks-Immune|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.25e-05 | 198 | 82 | 5 | 5dff131356b8c22743bd27b2b21f86ee6e4a0a0d | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_B|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.25e-05 | 198 | 82 | 5 | 0dc4a564dcab8ac42f238f98ee1f2090b0dcffe6 | |
| ToppCell | 390C-Lymphocytic-NK_cells|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.25e-05 | 198 | 82 | 5 | 623e5ada1a54cd42c32a1519b84dbe782384ee0c | |
| ToppCell | (0)_NK_cells-(0)_NK_FCGR3Apos|(0)_NK_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 3.25e-05 | 198 | 82 | 5 | eba39656c6f699ab297b652ded8cb9727b49593c | |
| ToppCell | 390C-Lymphocytic-NK_cells|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.25e-05 | 198 | 82 | 5 | 872ddb2738c5e0375830bb0e5b2c50383bf58738 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.33e-05 | 199 | 82 | 5 | f34c15df58fbdc6c90e30800e26fabbf828ad10b | |
| ToppCell | distal-Hematologic-Natural_Killer-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.33e-05 | 199 | 82 | 5 | 928b152f3bade90dfdb15e46aaa0c85063db0026 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.33e-05 | 199 | 82 | 5 | 5ceeed92f831d068ff4bb3994f420002338330e7 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.33e-05 | 199 | 82 | 5 | 0902b08e3386e64d7347c186d9ce5b67f2deaabb | |
| ToppCell | distal-Hematologic-Natural_Killer-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.33e-05 | 199 | 82 | 5 | af6516ac364202c5024694b92df903a04caea823 | |
| ToppCell | mild_COVID-19-NK|mild_COVID-19 / disease group, cell group and cell class (v2) | 3.33e-05 | 199 | 82 | 5 | 4854f25ee436e1cf577744373ffd87b1221d2b88 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.33e-05 | 199 | 82 | 5 | 00ef3cc5c02639bfb839075ecf5f20026ff81f84 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.33e-05 | 199 | 82 | 5 | 8e9862907b15809d083216e7d6a0f435015e5d15 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Mesenchymal|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 3.41e-05 | 200 | 82 | 5 | 0eccf41edefc3b8b5d0316f57d5ba572949aec2b | |
| ToppCell | mild-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.41e-05 | 200 | 82 | 5 | d8aec4904c9420b8f9d7508658ba1e36c66cdfcc | |
| ToppCell | Hematolymphoid-Microglia-TYROBP----L1-3|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.41e-05 | 200 | 82 | 5 | a20dce14f94777687aad57d6fbe3258ad376f63f | |
| ToppCell | MS-IIF-Lymphocyte-T/NK-NK|IIF / Disease, condition lineage and cell class | 3.41e-05 | 200 | 82 | 5 | 4f889cc5ab76a128fd781d927b0d8368f4f927b7 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.41e-05 | 200 | 82 | 5 | dc344b3ec51d506952e38f0b3a7795d65f9dd4eb | |
| ToppCell | Hematolymphoid-Microglia-TYROBP-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.41e-05 | 200 | 82 | 5 | 3bba5219453322198e8fdb0921d5f8c403598751 | |
| ToppCell | Hematolymphoid-Microglia|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.41e-05 | 200 | 82 | 5 | 21bcca3b670fe9bac034aef2275d3de4a9a73e2b | |
| Drug | lanthanum | 3.56e-08 | 136 | 83 | 8 | CID000023926 | |
| Drug | R 478 | 5.31e-08 | 11 | 83 | 4 | CID000084223 | |
| Drug | propranolol | CACNA1B CACNA2D2 NETO1 APOB DBH PLD2 ATP2A1 ATP2A3 ADCY6 RYR1 RYR2 ITPR3 | 5.64e-08 | 434 | 83 | 12 | CID000004946 |
| Drug | Bay K 8644 | 7.64e-08 | 150 | 83 | 8 | CID000002303 | |
| Drug | lercanidipine | 1.12e-07 | 63 | 83 | 6 | CID000065866 | |
| Drug | CNS 1145 | 1.25e-07 | 33 | 83 | 5 | CID000190902 | |
| Drug | IHC-64 | 1.25e-07 | 33 | 83 | 5 | CID000162753 | |
| Drug | D-myo-inositol-1,4,5-triphosphate | CACNA1B RASA3 CACNA2D2 CIB3 PI4KA ANXA7 PLD2 ATP2A1 ATP2A3 ADCY6 RYR1 RYR2 ITPR3 | 1.35e-07 | 568 | 83 | 13 | CID000000806 |
| Drug | strontium | 1.78e-07 | 68 | 83 | 6 | CID000104798 | |
| Drug | AC1L2AC7 | 1.95e-07 | 69 | 83 | 6 | CID000068733 | |
| Drug | mag-fura-2 | 2.27e-07 | 37 | 83 | 5 | CID000123839 | |
| Drug | papaverine | 2.62e-07 | 176 | 83 | 8 | CID000004680 | |
| Drug | CAS 298-57-7 | 2.74e-07 | 73 | 83 | 6 | CID000002761 | |
| Drug | ethosuximide | 2.97e-07 | 74 | 83 | 6 | CID000003291 | |
| Drug | AC1L1KS5 | CACNA1B NPR3 CACNA2D2 PLD2 ATP2A1 ATP2A3 ADCY6 RYR1 RYR2 ITPR3 | 3.80e-07 | 334 | 83 | 10 | CID000005631 |
| Drug | bepridil | 3.94e-07 | 126 | 83 | 7 | CID000002351 | |
| Drug | pimozide | 4.15e-07 | 127 | 83 | 7 | CID000016362 | |
| Drug | AC1L380G | 6.10e-07 | 19 | 83 | 4 | CID000084698 | |
| Drug | XeC compound | 6.33e-07 | 84 | 83 | 6 | CID000005701 | |
| Drug | AC1Q7BER | 9.27e-07 | 6 | 83 | 3 | CID000005702 | |
| Drug | nimodipine | 1.02e-06 | 145 | 83 | 7 | CID000004497 | |
| Drug | Dantrolene-13C3 | 1.02e-06 | 145 | 83 | 7 | CID000002951 | |
| Drug | AC1MMLID | 1.08e-06 | 92 | 83 | 6 | CID000013245 | |
| Drug | cobalt-60 | 1.55e-06 | 390 | 83 | 10 | CID000061492 | |
| Drug | [[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate | 1.62e-06 | 7 | 83 | 3 | CID009547999 | |
| Drug | Br2BAPTA | 1.62e-06 | 7 | 83 | 3 | CID003081001 | |
| Drug | verapamil | CACNA1B CYP2E1 CACNA2D2 APOB ATP2A1 ATP2A3 ADCY6 RYR1 RYR2 KCNH5 ITPR3 | 1.64e-06 | 490 | 83 | 11 | CID000002520 |
| Drug | isradipine | 1.77e-06 | 100 | 83 | 6 | CID000003784 | |
| Drug | oxalate | 1.81e-06 | 158 | 83 | 7 | CID000000971 | |
| Drug | Cinildipine | 1.88e-06 | 56 | 83 | 5 | CID000002752 | |
| Drug | halothane | 2.16e-06 | 314 | 83 | 9 | CID000003562 | |
| Drug | nilvadipine | 2.66e-06 | 60 | 83 | 5 | CID000004494 | |
| Drug | nifedipine | NPC1 CACNA1B CYP2E1 CACNA2D2 ATP2A1 ATP2A3 RYR1 RYR2 TFR2 ITPR3 | 2.70e-06 | 415 | 83 | 10 | CID000004485 |
| Drug | IAA-94 | 2.89e-06 | 61 | 83 | 5 | CID000003667 | |
| Drug | cyclophorine | CACNA1B CYP2E1 CACNA2D2 NETO1 APOB PLD2 ADCY6 RYR1 RYR2 ITPR3 | 3.41e-06 | 426 | 83 | 10 | CID000002909 |
| Drug | TMB-8 | 3.71e-06 | 176 | 83 | 7 | CID000005494 | |
| Drug | 4-hydroxyoctenal | 3.86e-06 | 9 | 83 | 3 | CID005283334 | |
| Drug | fura 2 | 3.96e-06 | 65 | 83 | 5 | CID000057054 | |
| Drug | AC1NBU2S | 4.43e-06 | 117 | 83 | 6 | CID004473765 | |
| Drug | gallopamil | 4.61e-06 | 67 | 83 | 5 | CID000001234 | |
| Drug | NSC7524 | 4.62e-06 | 182 | 83 | 7 | CID000005657 | |
| Drug | NSC3364 | 4.65e-06 | 118 | 83 | 6 | CID000025439 | |
| Drug | fluo-3 | 5.64e-06 | 122 | 83 | 6 | CID000104978 | |
| Drug | Clorocruoro Hem | 5.91e-06 | 123 | 83 | 6 | CID003518809 | |
| Drug | NSC759576 | 6.35e-06 | 191 | 83 | 7 | CID000003075 | |
| Drug | dihydropyridine | 6.80e-06 | 193 | 83 | 7 | CID000104822 | |
| Drug | myo-inositol | CACNA1B TBC1D4 RASA3 CACNA2D2 PI4KA FLRT3 PLD2 ATP2A1 ATP2A3 ADCY6 RYR1 RYR2 ITPR3 | 7.14e-06 | 811 | 83 | 13 | CID000000892 |
| Drug | 2,3-dichlorobutane | 7.55e-06 | 11 | 83 | 3 | CID000024233 | |
| Drug | 8-amino-cADPR | 7.55e-06 | 11 | 83 | 3 | CID003081323 | |
| Drug | rapamycin; Down 200; 0.1uM; HL60; HG-U133A | 7.77e-06 | 197 | 83 | 7 | 362_DN | |
| Drug | Tiletamine hydrochloride; Down 200; 15.4uM; PC3; HT_HG-U133A | 8.30e-06 | 199 | 83 | 7 | 7311_DN | |
| Drug | C070379 | 8.30e-06 | 199 | 83 | 7 | CID003034747 | |
| Drug | AC1L1IZE | 8.49e-06 | 131 | 83 | 6 | CID000004799 | |
| Drug | nisoldipine | 9.76e-06 | 78 | 83 | 5 | CID000004499 | |
| Drug | 4-chloro-m-cresol | 9.89e-06 | 37 | 83 | 4 | CID000001732 | |
| Drug | Colprone | 1.00e-05 | 12 | 83 | 3 | CID000013790 | |
| Drug | N-cyclopentyl-N-cyclobutylformamide | 1.04e-05 | 79 | 83 | 5 | CID005287890 | |
| Drug | Fura-2AM | 1.04e-05 | 79 | 83 | 5 | CID000105091 | |
| Drug | B151 | 1.31e-05 | 2 | 83 | 2 | CID000063117 | |
| Drug | adenophostin A | 1.31e-05 | 2 | 83 | 2 | ctd:C085029 | |
| Drug | Cholesterylene | 1.31e-05 | 2 | 83 | 2 | CID000092835 | |
| Drug | 3,8-dihydroxyquinoline | 1.31e-05 | 2 | 83 | 2 | CID000177338 | |
| Drug | phenytoin | 1.55e-05 | 219 | 83 | 7 | CID000001775 | |
| Drug | escina | 1.99e-05 | 44 | 83 | 4 | CID006433489 | |
| Drug | Gvapspat amide | 2.06e-05 | 15 | 83 | 3 | CID000125015 | |
| Drug | CaCl2 | 2.30e-05 | 156 | 83 | 6 | CID000024854 | |
| Drug | 3-(1H-pyrrole-2-carboxylate | 2.30e-05 | 233 | 83 | 7 | CID000005114 | |
| Drug | 4-vinylphenol | 2.53e-05 | 16 | 83 | 3 | CID000062453 | |
| Drug | manidipine | 2.55e-05 | 95 | 83 | 5 | CID000004008 | |
| Drug | lysosphingomyelin | 2.65e-05 | 160 | 83 | 6 | CID000005263 | |
| Drug | AC1L1KC5 | CACNA1B CACNA2D2 WFS1 PI4KA PLD2 ATP2A1 ATP2A3 RYR1 RYR2 ITPR3 | 2.71e-05 | 541 | 83 | 10 | CID000005428 |
| Drug | isotetrandrine | 2.82e-05 | 97 | 83 | 5 | CID000005422 | |
| Drug | ts M | 2.83e-05 | 48 | 83 | 4 | CID000428025 | |
| Drug | nitrendipine | 2.97e-05 | 98 | 83 | 5 | CID000004507 | |
| Drug | clinofibrate | 3.06e-05 | 17 | 83 | 3 | CID000002787 | |
| Drug | carbon disulfide | 3.06e-05 | 17 | 83 | 3 | CID000006348 | |
| Drug | isoproterenol | CACNA1B NPR3 TBC1D4 MYO9B DBH PLD2 ATP2A1 ATP2A3 ADCY6 RYR1 RYR2 | 3.07e-05 | 669 | 83 | 11 | CID000003779 |
| Drug | indo-1 | 3.12e-05 | 99 | 83 | 5 | CID000105060 | |
| Drug | gabapentin | 3.60e-05 | 169 | 83 | 6 | CID000003446 | |
| Drug | felodipine | 3.60e-05 | 169 | 83 | 6 | CID000003333 | |
| Drug | caffeine | CACNA1B CYP2E1 CACNA2D2 PLD2 ATP2A1 ATP2A3 ADCY6 RYR1 RYR2 ITPR3 | 3.74e-05 | 562 | 83 | 10 | CID000002519 |
| Drug | D05547 | 3.93e-05 | 3 | 83 | 2 | CID010154203 | |
| Drug | Tris-Gal-Chol | 3.93e-05 | 3 | 83 | 2 | CID000174825 | |
| Drug | 2,4,6-trimethylpyrylium | 3.93e-05 | 3 | 83 | 2 | CID000135854 | |
| Drug | cis-diammineplatinum(II | 3.93e-05 | 3 | 83 | 2 | CID000159790 | |
| Drug | 2-hydroxyheptanoic acid | 3.93e-05 | 3 | 83 | 2 | CID002750949 | |
| Drug | 8N3-cADPR | 3.93e-05 | 3 | 83 | 2 | CID000127713 | |
| Drug | aminodantrolene | 3.93e-05 | 3 | 83 | 2 | CID009570289 | |
| Drug | CGP 43371 | 3.93e-05 | 3 | 83 | 2 | CID006441203 | |
| Drug | 2-oxononanal | 3.93e-05 | 3 | 83 | 2 | CID000142757 | |
| Drug | CGS 24565 | 3.93e-05 | 3 | 83 | 2 | CID006443293 | |
| Drug | 2-hydroxycarbazole | 3.93e-05 | 3 | 83 | 2 | CID000093551 | |
| Drug | pirozadil | 3.93e-05 | 3 | 83 | 2 | CID000068711 | |
| Drug | Ryanodyl 3-(pyridine-3-carboxylate | 3.93e-05 | 3 | 83 | 2 | CID005748312 | |
| Drug | phenylglyoxylic acid | 3.93e-05 | 3 | 83 | 2 | ctd:C012482 | |
| Drug | mandelic acid | 3.93e-05 | 3 | 83 | 2 | ctd:C037938 | |
| Drug | vinylcyclohexane | 3.93e-05 | 3 | 83 | 2 | CID000012757 | |
| Drug | C2(+) | 3.93e-05 | 3 | 83 | 2 | CID006857645 | |
| Drug | copper nitride | 3.93e-05 | 3 | 83 | 2 | CID000061847 | |
| Drug | carbachol | CACNA1B NPR3 CACNA2D2 PI4KA PLD2 ATP2A1 ATP2A3 ADCY6 RYR1 RYR2 ITPR3 | 3.96e-05 | 688 | 83 | 11 | CID000002551 |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 2.23e-05 | 3 | 81 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | Brody myopathy (implicated_via_orthology) | 2.23e-05 | 3 | 81 | 2 | DOID:0050692 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 2.23e-05 | 3 | 81 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | procollagen C-endopeptidase enhancer 1 measurement | 1.11e-04 | 6 | 81 | 2 | EFO_0801920 | |
| Disease | atrioventricular septal defect (implicated_via_orthology) | 1.55e-04 | 7 | 81 | 2 | DOID:0050651 (implicated_via_orthology) | |
| Disease | heart disease (implicated_via_orthology) | 1.57e-04 | 38 | 81 | 3 | DOID:114 (implicated_via_orthology) | |
| Disease | Hereditary Sensory Autonomic Neuropathy, Type 1 | 2.06e-04 | 8 | 81 | 2 | C0020071 | |
| Disease | Jeune thoracic dystrophy | 4.03e-04 | 11 | 81 | 2 | C0265275 | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 4.83e-04 | 12 | 81 | 2 | DOID:1441 (implicated_via_orthology) | |
| Disease | 3-hydroxyphenylacetic acid measurement | 6.63e-04 | 14 | 81 | 2 | EFO_0010448 | |
| Disease | Tremor, Rubral | 8.71e-04 | 16 | 81 | 2 | C0750940 | |
| Disease | Ataxia, Appendicular | 8.71e-04 | 16 | 81 | 2 | C0750937 | |
| Disease | Ataxia, Motor | 8.71e-04 | 16 | 81 | 2 | C0278161 | |
| Disease | Ataxia, Sensory | 8.71e-04 | 16 | 81 | 2 | C0240991 | |
| Disease | Abnormal coordination | 8.71e-04 | 16 | 81 | 2 | C0520966 | |
| Disease | Ataxia, Truncal | 8.71e-04 | 16 | 81 | 2 | C0427190 | |
| Disease | Non-alcoholic Fatty Liver Disease | 9.55e-04 | 70 | 81 | 3 | C0400966 | |
| Disease | Nonalcoholic Steatohepatitis | 9.55e-04 | 70 | 81 | 3 | C3241937 | |
| Disease | epilepsy (implicated_via_orthology) | 1.07e-03 | 163 | 81 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | asparaginase hypersensitivity | 1.26e-03 | 77 | 81 | 3 | EFO_0004881 | |
| Disease | Myocardial Ischemia | 1.42e-03 | 176 | 81 | 4 | C0151744 | |
| Disease | Cardiomegaly | 1.51e-03 | 82 | 81 | 3 | C0018800 | |
| Disease | Cardiac Hypertrophy | 1.51e-03 | 82 | 81 | 3 | C1383860 | |
| Disease | Lymphoma, Diffuse | 1.51e-03 | 21 | 81 | 2 | C3714542 | |
| Disease | Low Grade Lymphoma (neoplasm) | 1.51e-03 | 21 | 81 | 2 | C0079747 | |
| Disease | Lymphoma, Intermediate-Grade | 1.51e-03 | 21 | 81 | 2 | C0079741 | |
| Disease | High Grade Lymphoma (neoplasm) | 1.51e-03 | 21 | 81 | 2 | C0079740 | |
| Disease | Diffuse Mixed-Cell Lymphoma | 1.51e-03 | 21 | 81 | 2 | C0079757 | |
| Disease | Lymphoma, Undifferentiated | 1.51e-03 | 21 | 81 | 2 | C0024306 | |
| Disease | Reticulosarcoma | 1.51e-03 | 21 | 81 | 2 | C0024302 | |
| Disease | Lymphoma, Mixed-Cell | 1.51e-03 | 21 | 81 | 2 | C0024304 | |
| Disease | Lymphoma, Non-Hodgkin, Familial | 1.66e-03 | 22 | 81 | 2 | C4721532 | |
| Disease | Lymphoma, Small Noncleaved-Cell | 1.66e-03 | 22 | 81 | 2 | C0079770 | |
| Disease | Coronary heart disease | 1.98e-03 | 24 | 81 | 2 | C0010068 | |
| Disease | Dyslipidemias | 1.98e-03 | 24 | 81 | 2 | C0242339 | |
| Disease | Dyslipoproteinemias | 1.98e-03 | 24 | 81 | 2 | C0598784 | |
| Disease | malaria (is_implicated_in) | 1.98e-03 | 24 | 81 | 2 | DOID:12365 (is_implicated_in) | |
| Disease | alcohol use disorder (implicated_via_orthology) | 2.07e-03 | 195 | 81 | 4 | DOID:1574 (implicated_via_orthology) | |
| Disease | Ataxia | 2.14e-03 | 25 | 81 | 2 | C0004134 | |
| Disease | glycerol measurement | 2.32e-03 | 26 | 81 | 2 | EFO_0010115 | |
| Disease | digestive system infectious disorder | 2.32e-03 | 26 | 81 | 2 | MONDO_0043424 | |
| Disease | Micronuclei, Chromosome-Defective | 2.32e-03 | 26 | 81 | 2 | C1449861 | |
| Disease | Micronuclei, Genotoxicant-Induced | 2.32e-03 | 26 | 81 | 2 | C1449862 | |
| Disease | hepatitis C (is_implicated_in) | 2.69e-03 | 28 | 81 | 2 | DOID:1883 (is_implicated_in) | |
| Disease | tuberculosis (is_implicated_in) | 2.69e-03 | 28 | 81 | 2 | DOID:399 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HFILKNYDIQYFSMR | 206 | P78540 | |
| NLMLALYNNSFYTRK | 921 | Q9NY47 | |
| LERLYQRYFFQMNQS | 136 | O43306 | |
| AFSYLRQLYRLDMSN | 266 | Q9NZU0 | |
| KSEFRQNLGRMYLFY | 766 | O95782 | |
| CDLFQRRMLETAYKY | 2756 | Q96DT5 | |
| NRPAFFAERLYYAMK | 416 | P20073 | |
| VRICKFLRYFFYKSM | 991 | O60423 | |
| EFQLLQRNFMDKYYL | 36 | Q9Y2Y0 | |
| FRFFIRRMVKAQSFY | 471 | Q00975 | |
| FYYRRVRKMSNAELA | 141 | Q96KC8 | |
| FRAYIFAMKVLASYQ | 1616 | Q8IZT6 | |
| ISLQSYFRMRKARQY | 1756 | Q8IZT6 | |
| RAIYNNMKQFIRYLI | 751 | O14983 | |
| RAIYSNMKQFIRYLI | 751 | Q93084 | |
| GLLMAFYFFRKKYRI | 496 | P17342 | |
| FLYKDENRTRYAFVM | 316 | Q8IXT5 | |
| RSKIYLRFLDYEMQN | 211 | Q8TDF5 | |
| ERIYSLFNLYMSKLE | 731 | Q14644 | |
| YNDEKFLRLMYLFNE | 191 | P05181 | |
| VLTYYRYQLNLFARM | 726 | Q14571 | |
| LSYYRYQLKLFARMC | 726 | Q14573 | |
| YQLKLFARMCLDRQY | 731 | Q14573 | |
| YRRGFNNFMLYKEDR | 51 | P43630 | |
| NVQYFLDRFYMSRIS | 176 | Q15118 | |
| QYFLDRFYMNRISTR | 156 | Q16654 | |
| FLFNMYLTRDRRYEV | 211 | P31274 | |
| TLTNLRKGYLFMYNL | 141 | Q9P035 | |
| YHEMLNNVRDFLKLY | 481 | Q8NCM2 | |
| YRHRFNNFMLYKEDR | 51 | P43629 | |
| RVFDMLNRRYLSPKY | 161 | P60842 | |
| RYNFIRSMAAYSLLL | 1936 | P42356 | |
| FYQVRARLAMLEKNY | 681 | Q9UG01 | |
| AKSQIFQIFYFRMYL | 1216 | O15118 | |
| LENYQILQYFIIRMF | 286 | Q4JDL3 | |
| NFREFYYIQMEKSAR | 486 | Q3B8N5 | |
| YSLYEAVKFLMLNRA | 226 | Q96BN8 | |
| MNYRLRPLEKFVTYF | 436 | Q8IZJ4 | |
| TVMDFRKFSRNYQLY | 626 | P04114 | |
| RIFYKLMLRLGFQEF | 206 | P07099 | |
| ASALLYLLMRNNFEY | 1501 | Q5JSL3 | |
| VTYFEKNFNLRRFMY | 1881 | Q8NF50 | |
| LYYTAKLRRFNAGIM | 351 | P09172 | |
| SFINRNYRYELMKAF | 316 | P25106 | |
| ILDFMLRYLYSQKES | 76 | Q6DD88 | |
| YLQARFSYVRMKYLF | 16 | Q5T7M9 | |
| QRSFRYYLFSLIMNL | 121 | O96011 | |
| MKFFSYILVYRRFLF | 1 | Q9BZW2 | |
| KFLNYLSRNFYTLRF | 4551 | P21817 | |
| LLNYFARNFYNMRML | 4491 | Q92736 | |
| ANYLFFLMYLINKDE | 4916 | Q92736 | |
| VIRDYLYALNSKRMF | 481 | Q86V97 | |
| LYRFLLETMAYVKNN | 1586 | A6NES4 | |
| YFYKFMINLLKRFSS | 526 | Q08AM6 | |
| IMEDYFAFRNFLYLR | 1081 | P51531 | |
| YLILDEYMRFLNCRK | 301 | Q8WXG1 | |
| YFLQYIRETNIRDMF | 716 | Q9UBV2 | |
| YLTALRMFNRTYKLY | 276 | O75354 | |
| IRANYNSAKMALYRL | 671 | P25391 | |
| YRHRFNNFMLYKEDR | 51 | Q14943 | |
| YLFRLYMALKQYREA | 1091 | Q8NEZ3 | |
| LSYAMRRSYRYKLLN | 161 | Q6NZ63 | |
| FTMKQNLEAYRYLNF | 676 | P55201 | |
| FFTRKEIMRLFYRYQ | 21 | Q96Q77 | |
| FYRKFAVPMLRLYAN | 266 | Q9NRB3 | |
| ISPFYQRRLFDLYKM | 311 | Q8NET6 | |
| QDFENFYTRNLYMRI | 116 | O15270 | |
| YRRYSKFFDLQMQLL | 41 | Q5TCZ1 | |
| LFLVLDDNFYYQSMR | 146 | Q8IV42 | |
| FLLLQRRVFMSYYFL | 1421 | Q9H5I5 | |
| RKMADFFLIQSNYNY | 186 | Q8WW62 | |
| FLDDVRRMNKRQLYY | 6 | P67812 | |
| RRMNKRQLYYQVLNF | 11 | P67812 | |
| LKFLMYDLGFRKQYR | 1031 | O60343 | |
| NKYVNLVMYFLFRLA | 171 | Q96CP7 | |
| LLQRAVNIFMEYYRK | 1141 | Q8N9V7 | |
| EYLLRMFQQTFYLLQ | 331 | Q96QU8 | |
| YRNPEDYKRLFFRFM | 2376 | O15050 | |
| CERTFKRLYQYMLNA | 286 | Q12789 | |
| LENYLNRLLTMSFYR | 166 | O14939 | |
| YNVRIMRVEFYFLSQ | 706 | Q9UP52 | |
| NLYRKVMFENYRNLV | 36 | Q8NEM1 | |
| RSFYLALYKQMSFLE | 341 | Q9BQ70 | |
| RQKLLMFLEISSYYD | 661 | Q96JC1 | |
| LLYLFFRMAQLRNFK | 511 | O76024 | |
| NLRKRFMDDYIFTYI | 36 | O00160 | |
| FALADVAYYTMLRKR | 216 | Q13459 |